UnknownNot Applicable

HABIT-ILE in Adults With Chronic Stroke (HABIT-ILE Stroke)

Belgium48 participantsStarted 2020-12-15

Plain-language summary

Using a randomized controlled trial design, the possible changes induced by the intensive treatment program "Hand-arm Bimanual Intensive Therapy Including Lower Extremities (HABIT-ILE)" will be studied in functional, everyday life activities and neuroplastic assessment of adults with chronic stroke.

Who can participate

Age range

40 Years – 90 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * hemiparetic patient with a chronic stroke (over 6 months of evolution) * age 40 to 90 years old inclusive * ability to follow instructions and complete testing according to the age. Exclusion Criteria: * alcohol/drug abuse * pregnancy * major cognitive impairment interfering with the study (severe aphasia, psychiatric conditions) * uncontrolled health issues (cardiac/renal failure) * contraindications to perform MRI assessments (Metal implants, etc.)

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Changes on the Adult Assisting Hand Assessment Stroke (Ad-AHA Stroke)

Timeframe: baseline, 3 weeks and 13 weeks after baseline

Trial details

NCT IDNCT04664673

SponsorUniversité Catholique de Louvain

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-11

Contact for this trial

Yves Vandermeeren, PhD

+3281423321 yves.vandermeeren@uclouvain.be

View on ClinicalTrials.gov More Stroke trials